AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Trial: 3127965
Drug: Oxamniquine at
RxNorm normalized name: oxamniquine
DrugBank: Oxamniquine (DB01096)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Oxamniquine at 40 mg/kg
Trial: 3127965
Drug: Praziquantel at
RxNorm normalized name: Praziquantel
DrugBank: Praziquantel (DB01058)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Praziquantel at 20 mg/kg
Trial: 3127965
Drug: Praziquantel at
RxNorm normalized name: Praziquantel
DrugBank: Praziquantel (DB01058)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Praziquantel at 30 mg/kg
Trial: 3127965
Drug: Praziquantel at
RxNorm normalized name: Praziquantel
DrugBank: Praziquantel (DB01058)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Praziquantel at 40 mg/kg
Trial: 31451351
Drug: Amikacin liposome
RxNorm normalized name: AMIKACIN LIPOSOME
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Amikacin liposome inhalation suspension (ALIS, 590 mg QD)
Trial: 31451351
Drug: Tobramycin inhalation
RxNorm normalized name: Tobramycin Inhalation Powder
DrugBank: Tobramycin (DB00684)
FDA approved: yes
EMA approved: yes
PMDA approved: no
Description: Tobramycin inhalation solution (TIS, 300 mg BID)
Trial: 29145631
Drug: Rifaximin 550
RxNorm normalized name: rifAXIMin 550 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Rifaximin 550 mg twice daily for 3 days
Trial: 22879633
Drug: Metformin 850
RxNorm normalized name: metFORMIN 850 mg oral tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Metformin 850 mg twice a day
Trial: 20470299
Drug: Twice daily
RxNorm normalized name: CAPSULE, TWICE DAILY
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Twice daily icodextrin
Trial: 20470299
Drug: Once daily
RxNorm normalized name: GEL, ONCE DAILY
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Once daily icodextrin
Trial: 16634988
Drug: Sibutramine with
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sibutramine with cognitive-behavioural weight loss treatment
Trial: 16634988
Drug: Cognitive-behavioural weight
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cognitive-behavioural weight loss treatment alone
Trial: 8815168
Drug: D-ribose (60
FDA approved: no
EMA approved: no
PMDA approved: no
Description: D-ribose (60 g daily for 7 days)
Trial: 6436879
Drug: Ultra-low yielding
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ultra-low yielding cigarette (0.1 mg nicotine) for 10 days
Trial: 28370266
Drug: Mometasone furoate
RxNorm normalized name: Mometasone Furoate
DrugBank: Mometasone furoate (DB14512)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Mometasone furoate 220 mcg dry powder inhalation
Trial: 26978751
Drug: Streptococcus salivarius
RxNorm normalized name: Streptococcus salivarius
DrugBank: Streptococcus salivarius (DB19274)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Streptococcus salivarius K12‐based probiotic complex during 30 days in combination with nasal douche
Trial: 14747210
Drug: cPPG >150
FDA approved: no
EMA approved: no
PMDA approved: no
Description: cPPG >150 mg/dl
Trial: 10532976
Drug: Hybrid laser
RxNorm normalized name: Amaranthus hybridus pollen
DrugBank: Amaranthus hybridus pollen (DB15503)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Hybrid laser treatment
Trial: 3169116
Drug: Inhaled adenosine
RxNorm normalized name: Adenosine
DrugBank: Adenosine phosphate (DB00131)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Inhaled adenosine at a concentration of 5 mg.ml‐1
Trial: 3169116
Drug: Infusion of
RxNorm normalized name: OIL OF CAMPHOR
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Infusion of a comparable dose of adenosine
Trial: 31253145
Drug: Volar plating
RxNorm normalized name: platinic chloride
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Volar plating (surgical treatment with open reduction and internal fixation using volar locking plates)
Trial: 31253145
Drug: Conservative treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Conservative treatment (closed reduction and plaster immobilization)
Trial: 28403911
Drug: Usual care
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Usual care with monthly social assistance, domotic, and remote assistance
Trial: 21994429
Drug: U-500R insulin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: U-500R insulin (50 units)
Trial: 21994429
Drug: U-500R insulin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: U-500R insulin (100 units)
Trial: 21994429
Drug: U-100R insulin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: U-100R insulin (50 units)
Trial: 21994429
Drug: U-100R insulin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: U-100R insulin (100 units)
Trial: 10873167
Drug: Enhanced inactivated
RxNorm normalized name: diphtheria toxoid vaccine, inactivated / tetanus toxoid vaccine, inactivated Injection [Tdvax]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Enhanced inactivated poliovirus vaccine (IPV) administered intramuscularly within 24 hours of birth
Trial: 9351723
Drug: Control group
RxNorm normalized name: meningococcal group B vaccine Prefilled Syringe [Trumenba]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control group (CNTL) receiving intravenous crystalloid solutions
Trial: 8471660
Drug: Clodronate 1600
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Clodronate 1600 mg/day orally for at least 1 year
Trial: 8471660
Drug: Chemotherapy alone
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Chemotherapy alone (melphalan 15 mg/m2 i.v. and prednisolone 60 mg/m2 orally)
Trial: 30158069
Drug: Aspirin (100
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Aspirin (100 mg, enteric-coated, once daily)
Trial: 7776934
Drug: Placebo (once
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo (once daily)
Trial: 24888818
Drug: Initial therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Initial therapy (arm A)
Trial: 24888818
Drug: Initial therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Initial therapy (arm B)
Trial: 24888818
Drug: Continue initial
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Continue initial therapy (arm C1)
Trial: 24888818
Drug: Change to
RxNorm normalized name: Wong To Yick
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Change to alternative chemotherapy (arm C2)
Trial: 22071326
Drug: Diesel exhaust
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Diesel exhaust exposure (100 μg/m(3))
Trial: 15759056
Drug: Hirudin or
RxNorm normalized name: hirudin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Hirudin or Unfractionated heparin
Trial: 12583246
Drug: Integrating Western
RxNorm normalized name: western larch pollen extract
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Integrating Western and traditional Chinese medicine (IWTCM) including Chinese medicine and allopurinol
Trial: 7756102
Drug: 3 mg
RxNorm normalized name: boron 3 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 3 mg DU 29894
Trial: 7756102
Drug: 10 mg
RxNorm normalized name: biotin 10 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 10 mg DU 29894
Trial: 7756102
Drug: 1 mg
RxNorm normalized name: biotin 1 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 1 mg flesinoxan
Trial: 2110678
Drug: Tropical fish
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Tropical fish diet (500 g/day, rich in arachidonic acid and docosahexaenoic acid)
Trial: 2110678
Drug: Southern fish
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Southern fish diet (500 g/day, rich in docosahexaenoic acid)
Trial: 2110678
Drug: Kangaroo meat
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Kangaroo meat diet (500 g/day, rich in linoleic and arachidonic acids)
Trial: 393429
Drug: Sequential chemotherapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sequential chemotherapy regimen considering circadian rhythm (methotrexate or 5-FU, followed by vinblastine and cyclophosphamide)
Trial: 393429
Drug: Sequential chemotherapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sequential chemotherapy regimen without considering circadian rhythm (methotrexate or 5-FU, followed by vinblastine and cyclophosphamide)
Trial: 28356767
Drug: Guaifenesin 1200
RxNorm normalized name: guaifenesin 1200 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Guaifenesin 1200 mg BID
Trial: 28356767
Drug: Guaifenesin 600
RxNorm normalized name: guaifenesin 600 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Guaifenesin 600 mg BID
Trial: 28356767
Drug: Matched placebo
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Matched placebo (for 600 mg)
Trial: 25466702
Drug: Biperiden (2
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Biperiden (2 mg)
Trial: 25466702
Drug: Combination of
RxNorm normalized name: combination of rauwolfia alkaloids and diuretics incl. other combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination of biperiden and citalopram
Trial: 17400842
Drug: Sertraline (50
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sertraline (50 mg daily for 2 weeks, then 100 mg daily for 4 weeks)
Trial: 17400842
Drug: Placebo (identical
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo (identical to sertraline)
Trial: 15041109
Drug: Flutamide (FLU)
RxNorm normalized name: Flutamide
DrugBank: Flutamide (DB00499)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Flutamide (FLU) 250 mg t.i.d. p.o.
Trial: 15041109
Drug: Cyproterone acetate
RxNorm normalized name: cyproterone acetate
DrugBank: Cyproterone acetate (DB04839)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cyproterone acetate (CPA) 100 mg t.i.d. p.o.
Trial: 14728869
Drug: Bioadhesive nonoxynol-9
RxNorm normalized name: Nonoxynol 9
DrugBank: Nonoxynol-9 (DB06804)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Bioadhesive nonoxynol-9 gel
Trial: 14728869
Drug: Nonoxynol-9 suppository
RxNorm normalized name: Nonoxynol 9
DrugBank: Nonoxynol-9 (DB06804)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Nonoxynol-9 suppository
Trial: 7756203
Drug: Eicosapentaenoic acid
RxNorm normalized name: eicosapentaenoic acid
DrugBank: Icosapent (DB00159)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Eicosapentaenoic acid (3 g daily)
Trial: 2184795
Drug: Low-tryptophan diet
RxNorm normalized name: Tryptophan
DrugBank: Tryptophan (DB00150)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Low-tryptophan diet (160 mg/d for 24 hours) followed by a 16-amino acid drink
Trial: 399960
Drug: 5 ml
RxNorm normalized name: WATER,INHL 5 ML
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 5 ml of meglumine ioserinate (single dose)
Trial: 399960
Drug: 10 ml
RxNorm normalized name: Vial Empty 10 mL
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 10 ml of meglumine ioserinate (double dose)
Trial: 399960
Drug: meglumine ioserinate
RxNorm normalized name: Meglumine
DrugBank: Meglumine (DB09415)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: meglumine ioserinate (double dose)
Trial: 30449012
Drug: Intrauterine infusion
RxNorm normalized name: Duo Fusion
DrugBank: Magnesium hydroxide (DB09104)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Intrauterine infusion of 500 IU of hCG in 10 µL culture medium 4 minutes before ET
Trial: 30449012
Drug: Intrauterine infusion
RxNorm normalized name: Duo Fusion
DrugBank: Magnesium hydroxide (DB09104)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Intrauterine infusion of 500 IU of hCG
Trial: 28839337
Drug: AL 441
RxNorm normalized name: Al
DrugBank: Aluminium (DB01370)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: AL 441 mg every 4 weeks (n = 35)
Trial: 28839337
Drug: AL 882
RxNorm normalized name: Al
DrugBank: Aluminium (DB01370)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: AL 882 mg every 6 weeks (n = 34)
Trial: 28839337
Drug: AL 1064
RxNorm normalized name: Al
DrugBank: Aluminium (DB01370)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: AL 1064 mg every 8 weeks (n = 70)
Trial: 22648627
Drug: Grape extract
RxNorm normalized name: grape extract
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Grape extract supplement containing 8 mg resveratrol (Stilvid®)
Trial: 19243707
Drug: Long-term statin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Long-term statin treatment for > or =6 months before PCI (statin group, 44 patients)
Trial: 19243707
Drug: No long-term
RxNorm normalized name: benzethonium
DrugBank: Benzethonium (DB11125)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: No long-term statin treatment (nonstatin group, 56 patients)
Trial: 19243707
Drug: Long-term statin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Long-term statin treatment for > or =6 months before PCI (statin group)
Trial: 19243707
Drug: No long-term
RxNorm normalized name: benzethonium
DrugBank: Benzethonium (DB11125)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: No long-term statin treatment (nonstatin group)
Trial: 17304422
Drug: Amikacin 20
RxNorm normalized name: amikacin 20 MG/ML
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Amikacin 20 mg/kg/d in one dose
Trial: 17304422
Drug: Amikacin 10
RxNorm normalized name: amikacin 100 MG/ML
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Amikacin 10 mg/kg/d every 12 hours (Control)
Trial: 9880204
Drug: Captopril 50
RxNorm normalized name: captopril 50 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Captopril 50 mg + Prazosin 1 mg
Trial: 9880204
Drug: Hydralazine 30
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Hydralazine 30 mg + Isosorbide dinitrate 30 mg
Trial: 29486502
Drug: Video Capsule
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Video Capsule Endoscopy (VCE)
Trial: 21622538
Drug: Oral artesunate-amodiaquine
RxNorm normalized name: Amodiaquine
DrugBank: Amodiaquine (DB00613)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Oral artesunate-amodiaquine
Trial: 26335907
Drug: Root canal
RxNorm normalized name: Canal + Gel 10% for Root Canal Preparation Dental Gel
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Root canal treatment (RCT)
Trial: 11529827
Drug: 1 g
RxNorm normalized name: Molds 1 g
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 1 g of methylprednisolone sodium succinate on anesthetic induction (n = 6)
Trial: 9382758
Drug: Pseudomonas aeruginosa
RxNorm normalized name: Pseudomonas aeruginosa
DrugBank: Pseudomonas aeruginosa (DB19284)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Pseudomonas aeruginosa 5142/1210-Flagella Vaccine IMMUNO
Trial: 8516538
Drug: Isosorbide‐5‐mononitrate (IS‐5‐MN)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Isosorbide‐5‐mononitrate (IS‐5‐MN) 40 mg/12 hours from day 6 to 20, then 40 mg/8 hours from day 21 to 100
Trial: 6149939
Drug: bisoprolol 10
RxNorm normalized name: bisoprolol 10 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: bisoprolol 10 mg
Trial: 7793217
Drug: propranolol 40
RxNorm normalized name: propranolol 40 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: propranolol 40 mg
Trial: 31903689
Drug: Clinician-directed face-to-face
RxNorm normalized name: FACE SHIELD
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Clinician-directed face-to-face therapy (n = 26)
Trial: 31903689
Drug: Telepractice therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Telepractice therapy via 'SwallowIT' (n = 26)
Trial: 31903689
Drug: Patient self-directed
RxNorm normalized name: direct blue 2
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Patient self-directed therapy (n = 27)
Trial: 22515895
Drug: AH Plus
FDA approved: no
EMA approved: no
PMDA approved: no
Description: AH Plus with matched‐taper single‐cone technique
Trial: 22515895
Drug: MetaSEAL with
RxNorm normalized name: Primatene with ephedrine Pill
FDA approved: no
EMA approved: no
PMDA approved: no
Description: MetaSEAL with matched‐taper single‐cone technique
Trial: 21215227
Drug: Intravenous esmolol
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intravenous esmolol (0.5 mg/kg loading dose within 1 minute followed with infusion of 0.05 mg×kg(‐1)×min(‐1))
Trial: 21215227
Drug: Intravenous amiodarone
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intravenous amiodarone (loading dose: 3 mg/kg for 10 minutes, followed with intravenous infusion of 1 mg/min)
Trial: 21215227
Drug: Intravenous diltiazem
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intravenous diltiazem (0.25 mg/kg for 5 minutes)
Trial: 12006145
Drug: Nebulized taurolidine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Nebulized taurolidine (4 mL 2% solution)
Trial: 12006145
Drug: Saline (4
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Saline (4 mL 0.9% solution)
Trial: 1827615
Drug: 10 mg
RxNorm normalized name: biotin 10 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 10 mg of cetirizine once daily
Trial: 1827615
Drug: 60 mg
RxNorm normalized name: opium 60 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 60 mg of terfenadine twice daily
Trial: 30928825
Drug: Pitavastatin calcium
RxNorm normalized name: PITAVASTATIN CALCIUM
DrugBank: Pitavastatin (DB08860)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Pitavastatin calcium (4 mg/d)
Trial: 25168620
Drug: Edoxaban 15
RxNorm normalized name: edoxaban 15 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Edoxaban 15 mg once daily (QD) in patients with severe renal impairment
Trial: 25168620
Drug: Edoxaban with
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Edoxaban with co-administration of P-glycoprotein (P-gp) inhibitors
Trial: 25168620
Drug: Edoxaban with
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Edoxaban with IV dosing and co-administration of quinidine (a P-gp inhibitor)
Trial: 22374932
Drug: Group art
RxNorm normalized name: Streptococcus viridans group
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Group art therapy plus standard care
Trial: 17476001
Drug: Conventional physical
RxNorm normalized name: hypochlorite
DrugBank: Hypochlorite (DB11123)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Conventional physical therapy (3 weeks)
Trial: 15166013
Drug: Conventional doses
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Conventional doses of HRT (C‐HRT) - micronized progesterone 100 mg with conjugated equine estrogen 0.625 mg daily for 2 months
Trial: 15166013
Drug: Lower doses
RxNorm normalized name: flowers
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Lower doses of HRT (L‐HRT) - micronized progesterone 100 mg with conjugated equine estrogen 0.3 mg daily for 2 months
Trial: 15166013
Drug: Conventional doses
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Conventional doses of HRT (C‐HRT)
Trial: 15166013
Drug: Lower doses
RxNorm normalized name: flowers
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Lower doses of HRT (L‐HRT)
Trial: 7709781
Drug: Intrathecal administration
RxNorm normalized name: polidocanol
DrugBank: Polidocanol (DB06811)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Intrathecal administration of nicardipine (2 mg injected three times each day for an average of 10 days)
Trial: 3591260
Drug: 10(‐2) mol
RxNorm normalized name: MOL-4239
DrugBank: MOL-4239 (DB16051)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 10(‐2) mol l‐1 calcium ascorbate
Trial: 3591260
Drug: 10 mg
RxNorm normalized name: biotin 10 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 10 mg kg‐1 ascorbic acid
Trial: 29305946
Drug: Whole-grain diet
RxNorm normalized name: rice (whole grain) allergenic extract
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Whole-grain diet (50 g per 1000 kcal)
Trial: 27273130
Drug: Adjuvant chemotherapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Adjuvant chemotherapy with 5-fluorouracil/levamisole
Trial: 21311485
Drug: Akatinol memantine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Akatinol memantine (20 mg/day, 10 mg twice a day) for six months
Trial: 17655918
Drug: Topical imiquimod
RxNorm normalized name: imiquimod Topical Cream
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Topical imiquimod 5%
Trial: 2849682
Drug: Olive oil
RxNorm normalized name: Olive Oil
DrugBank: Olive oil (DB09567)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Olive oil supplement
Trial: 10499716
Drug: Noncompliance with
RxNorm normalized name: Primatene with ephedrine Pill
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Noncompliance with prescription medications
Trial: 10499716
Drug: Yearly medication
RxNorm normalized name: benzyl alcohol
DrugBank: Benzyl alcohol (DB06770)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Yearly medication costs
Trial: 7492102
Drug: Valaciclovir 1,000
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Valaciclovir 1,000 mg three times daily for 7 days
Trial: 7492102
Drug: Valaciclovir 1,000
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Valaciclovir 1,000 mg three times daily for 14 days
Trial: 8840413
Drug: Acyclovir 800
RxNorm normalized name: acyclovir 800 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Acyclovir 800 mg five times daily for 7 days
Trial: 27033879
Drug: Forest therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Forest therapy (staying at a recreational forest site)
Trial: 19443340
Drug: Pemetrexed, cisplatin,
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Pemetrexed, cisplatin, and radiation therapy followed by consolidation pemetrexed
Trial: 19443340
Drug: Etoposide, cisplatin,
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Etoposide, cisplatin, and radiation therapy followed by consolidation cytotoxic chemotherapy of choice
Trial: 18097810
Drug: Test product
RxNorm normalized name: Patch test product
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Test product (Glubosil, 30 mg)
Trial: 18097810
Drug: Reference product
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Reference product (Actos, 30 mg)
Trial: 11581139
Drug: ICD therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: ICD therapy in patients with ≥2 risk factors
Trial: 11581139
Drug: ICD therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: ICD therapy in patients with <2 risk factors
Trial: 9699906
Drug: Gemfibrozil (450
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Gemfibrozil (450 mg, twice a day)
Trial: 3709244
Drug: Killed influenza
RxNorm normalized name: INFLUENZA
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Killed influenza virus vaccine
Trial: 27927221
Drug: 400 IU
RxNorm normalized name: Vitamin D 400 IU Oral Tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 400 IU daily